sponsored
Half of high-risk patients fail to reach their LDL-C target
Research reveals treatment non-adherence is partly to blame
Cholesterol complacency and undertreatment are synonymous with cardiovascular disease, an Australian report suggests, with almost half of high-risk patients failing to reach recommended LDL-C targets.
The report by Baker Heart and Diabetes Institute and funded by Amgen analysed 10 years of data on almost 110,000 Australians with CVD.
It found that while 79% of participants were prescribed the recommended lipid lowering therapy,
